APA (7th ed.) Citation

AM, P., M, O., S, W. R., DK, D., J, F., EE, G., . . . MR, K. (2024). Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM. Neurology, 102(11), e209279. https://doi.org/10.1212/WNL.0000000000209279

Chicago Style (17th ed.) Citation

AM, Pack, et al. "Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM." Neurology 102, no. 11 (2024): e209279. https://doi.org/10.1212/WNL.0000000000209279.

MLA (9th ed.) Citation

AM, Pack, et al. "Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM." Neurology, vol. 102, no. 11, 2024, p. e209279, https://doi.org/10.1212/WNL.0000000000209279.